These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2158370)

  • 1. Evaluation of the effect of azapropazone on neutrophil migration in anaesthetized swine using a multichamber blister suction technique.
    Mousa SA; Brown R; Chan Y; Hsieh J; Smith RD
    Br J Pharmacol; 1990 Feb; 99(2):233-6. PubMed ID: 2158370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rat neutrophil functional responses by azapropazone, an anti-gout drug.
    Mackin WM; Rakich SM; Marshall CL
    Biochem Pharmacol; 1986 Mar; 35(6):917-22. PubMed ID: 3006696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of azapropazone on neutrophil migration in regional myocardial ischaemia/reperfusion injury in rabbits.
    Mousa SA; Brown R; Thoolen MJ; Smith RD
    Br J Pharmacol; 1990 Jun; 100(2):379-82. PubMed ID: 2165840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology and pharmacokinetics of azapropazone - a review.
    Jones CJ
    Curr Med Res Opin; 1976; 4(1):3-16. PubMed ID: 770078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)].
    Faust-Tinnefeldt G; Gilfrich HJ
    Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic evaluation of the effect of azapropazone on the gastric mucosa.
    Hradsky M; Bruce L
    Scand J Rheumatol; 1978; 7(1):31-2. PubMed ID: 675173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial cytoprotective efficacy of azapropazone in a swine model of regional myocardial ischemia/reperfusion injury.
    Mousa SA; Ritger R
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):51-8. PubMed ID: 1851140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy-azapropazone.
    Jahn U; Thiele K
    Arzneimittelforschung; 1988 Apr; 38(4):507-8. PubMed ID: 3401265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of azapropazone and allopurinol on myocardial infarct size in rats.
    Montor SG; Thoolen MJ; Mackin WM; Timmermans PB
    Eur J Pharmacol; 1987 Aug; 140(2):203-7. PubMed ID: 3666017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Experientia; 1978 Oct; 34(10):1320-1. PubMed ID: 738406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uricosuric action of azapropazone: dose-response and comparison with probenecid.
    Higgens CS; Scott JT
    Br J Clin Pharmacol; 1984 Sep; 18(3):439-43. PubMed ID: 6487482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.
    Geaney DP; Carver JG; Davies CL; Aronson JK
    Br J Clin Pharmacol; 1983 Jun; 15(6):727-34. PubMed ID: 6871071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A skin window study of neutrophil migration in subjects with localized juvenile periodontitis.
    Palmer GD; Watts TL; Addison IE
    J Clin Periodontol; 1993 Jul; 20(6):452-6. PubMed ID: 8349837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the potential interactions between azapropazone and frusemide in man.
    Williamson PJ; Ene MD; Roberts CJ
    Br J Clin Pharmacol; 1984 Oct; 18(4):619-23. PubMed ID: 6487503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of azapropazone on cellular events at inflamed sites. Influence on joint pathology in arthritic rats, leucocyte superoxide and eicosanoid production, platelet aggregation, synthesis of cartilage proteoglycans, synovial production and actions of interleukin-1 in cartilage resorption correlated with drug uptake into cartilage in-vitro.
    Rainsford KD; Davies A; Mundy L; Ginsburg I
    J Pharm Pharmacol; 1989 May; 41(5):322-30. PubMed ID: 2569519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
    Carolan EJ; Casale TB
    Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.